This episode reviews two recent papers on the practice-changing BEe-HIVe study, which assessed efficacy of a relatively new hepatitis B vaccine (known as HepB-CpG, or trade name Heplisav-B) for persons with HIV, and the resulting clinical implications. View episode transcript and references at www.hiv.uw.edu. This podcast explores practice-changing issues and updates in HIV diagnosis, management, and prevention. The three podcast hosts include Lead Editor Dr. Brian Wood, Professor of Medicin...
All content for National HIV Curriculum Podcast is the property of National HIV Curriculum and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
This episode reviews two recent papers on the practice-changing BEe-HIVe study, which assessed efficacy of a relatively new hepatitis B vaccine (known as HepB-CpG, or trade name Heplisav-B) for persons with HIV, and the resulting clinical implications. View episode transcript and references at www.hiv.uw.edu. This podcast explores practice-changing issues and updates in HIV diagnosis, management, and prevention. The three podcast hosts include Lead Editor Dr. Brian Wood, Professor of Medicin...
CROI 2025: CARES and BEeHIVe Studies and Their Potential Practice-Changing Impacts
National HIV Curriculum Podcast
23 minutes
6 months ago
CROI 2025: CARES and BEeHIVe Studies and Their Potential Practice-Changing Impacts
What were the CROI 2025 major scientific research themes and the key findings from the CARES trial on long-acting injectable ART and the BEeHIVe study on hepatitis B vaccines for people with HIV? Drs. Jehan Budak and Raaka Kumbhakar, co-assistant directors of a Ryan White-funded HIV Clinic, discuss major themes, the two studies, and how their clinical practice has already changed. View episode transcript and references at https://www.hiv.uw.edu/podcast/episode/conference-summaries/croi-2025-c...
National HIV Curriculum Podcast
This episode reviews two recent papers on the practice-changing BEe-HIVe study, which assessed efficacy of a relatively new hepatitis B vaccine (known as HepB-CpG, or trade name Heplisav-B) for persons with HIV, and the resulting clinical implications. View episode transcript and references at www.hiv.uw.edu. This podcast explores practice-changing issues and updates in HIV diagnosis, management, and prevention. The three podcast hosts include Lead Editor Dr. Brian Wood, Professor of Medicin...
